Home » Topics » Conferences

Conferences
RSS

Aceclofenac is effective and well tolerated in women with primary dysmenorrhea

May 5, 1999

NeuroBloc proves effective and safe in two pivotal trials in cervical dystonia

April 29, 1999

Botox in migraine, poststroke spasticity: results presented at AAN meeting

April 29, 1999

Open-label trial demonstrates efficacy of gabapentin monotherapy in AIDS-related neuropathy

April 29, 1999

Merck's Maxalt proves effective in women with menstrual migraine

April 29, 1999

Genzyme explores cell therapy for cardiovascular disease

April 29, 1999

Safety and efficacy of riluzole examined in pilot study in early, untreated PD

April 28, 1999

Lamotrigine effective in HIV-associated painful sensory polyneuropathy

April 28, 1999

Improvement in spasticity noted with small doses of Zanaflex

April 28, 1999

Preliminary evidence of efficacy and safety of N-acetylcysteine in AD

April 28, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...